These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 21532880)

  • 1. Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.
    Schauer IG; Sood AK; Mok S; Liu J
    Neoplasia; 2011 May; 13(5):393-405. PubMed ID: 21532880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.
    Schauer IG; Zhang J; Xing Z; Guo X; Mercado-Uribe I; Sood AK; Huang P; Liu J
    Neoplasia; 2013 Apr; 15(4):409-20. PubMed ID: 23555186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
    Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer.
    Yang Z; Jin P; Xu S; Zhang T; Yang X; Li X; Wei X; Sun C; Chen G; Ma D; Gao Q
    Cancer Lett; 2018 Feb; 415():20-29. PubMed ID: 29199004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.
    Lawrenson K; Grun B; Benjamin E; Jacobs IJ; Dafou D; Gayther SA
    Neoplasia; 2010 Apr; 12(4):317-25. PubMed ID: 20360942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal fibroblasts in cancer initiation and progression.
    Bhowmick NA; Neilson EG; Moses HL
    Nature; 2004 Nov; 432(7015):332-7. PubMed ID: 15549095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The origin of stroma surrounding epithelial ovarian cancer cells.
    Akahane T; Hirasawa A; Tsuda H; Kataoka F; Nishimura S; Tanaka H; Tominaga E; Nomura H; Chiyoda T; Iguchi Y; Yamagami W; Susumu N; Aoki D
    Int J Gynecol Pathol; 2013 Jan; 32(1):26-30. PubMed ID: 23202778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterotypic three-dimensional in vitro modeling of stromal-epithelial interactions during ovarian cancer initiation and progression.
    Lawrenson K; Grun B; Gayther SA
    J Vis Exp; 2012 Aug; (66):e4206. PubMed ID: 22951414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironment and pathogenesis of epithelial ovarian cancer.
    Saad AF; Hu W; Sood AK
    Horm Cancer; 2010 Dec; 1(6):277-90. PubMed ID: 21761359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGRN promotes migration and invasion of epithelial ovarian cancer cells through an epithelial mesenchymal transition program and the activation of cancer associated fibroblasts.
    Dong T; Yang D; Li R; Zhang L; Zhao H; Shen Y; Zhang X; Kong B; Wang L
    Exp Mol Pathol; 2016 Feb; 100(1):17-25. PubMed ID: 26607602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
    Ahmed N; Abubaker K; Findlay J; Quinn M
    J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.
    Jia D; Liu Z; Deng N; Tan TZ; Huang RY; Taylor-Harding B; Cheon DJ; Lawrenson K; Wiedemeyer WR; Walts AE; Karlan BY; Orsulic S
    Cancer Lett; 2016 Nov; 382(2):203-214. PubMed ID: 27609069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.
    Thuwajit C; Ferraresi A; Titone R; Thuwajit P; Isidoro C
    Med Res Rev; 2018 Jul; 38(4):1235-1254. PubMed ID: 28926101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer.
    Xu S; Yang Z; Jin P; Yang X; Li X; Wei X; Wang Y; Long S; Zhang T; Chen G; Sun C; Ma D; Gao Q
    Mol Cancer Ther; 2018 Jun; 17(6):1291-1302. PubMed ID: 29545331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer.
    Ryner L; Guan Y; Firestein R; Xiao Y; Choi Y; Rabe C; Lu S; Fuentes E; Huw LY; Lackner MR; Fu L; Amler LC; Bais C; Wang Y
    Clin Cancer Res; 2015 Jul; 21(13):2941-51. PubMed ID: 25838397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
    Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
    Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer.
    Chao TK; Yo YT; Liao YP; Wang YC; Su PH; Huang TS; Lai HC
    Gynecol Oncol; 2013 Mar; 128(3):475-82. PubMed ID: 23270808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment: The culprit for ovarian cancer metastasis?
    Luo Z; Wang Q; Lau WB; Lau B; Xu L; Zhao L; Yang H; Feng M; Xuan Y; Yang Y; Lei L; Wang C; Yi T; Zhao X; Wei Y; Zhou S
    Cancer Lett; 2016 Jul; 377(2):174-82. PubMed ID: 27131957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.
    Decio A; Taraboletti G; Patton V; Alzani R; Perego P; Fruscio R; Jürgensmeier JM; Giavazzi R; Belotti D
    Am J Pathol; 2014 Apr; 184(4):1050-1061. PubMed ID: 24508126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the tumour microenvironment in ovarian cancer.
    Hansen JM; Coleman RL; Sood AK
    Eur J Cancer; 2016 Mar; 56():131-143. PubMed ID: 26849037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.